Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: A mechanism of immune escape

Cancer Journal from Scientific American

Volumn 6, Issue SUPPL. 1, 2000, Pages

  Rayman, Patricia ^a   Uzzo, Robert G ^a   Kolenko, Vladimir ^a   Bloom, Tracy ^a   Cathcart, Martha K ^a   Molto, Luis ^a   Novick, Andy C ^a   Bukowski, Ronald M ^a   Hamilton, Thomas ^a   Finke, James H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Immune dysfunction; Interleukin 2; T cells; Transcription factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GANGLIOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; SYNAPSIN I; MESSENGER RNA; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR;

ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KIDNEY CARCINOMA; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; KIDNEY TUMOR; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; DOWN REGULATION; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION;

CARCINOMA, RENAL CELL; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; KIDNEY NEOPLASMS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0033995215     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Altman A, Coggeshall KM, Mustelin T. Molecular events mediating T cell activation. Adv Immunol 1990;48:227-360.
2. Ullman KS, Northrop JP, Verweij CL et al. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link Annu Rev Immunol 1990;8:421-52.
3. Minami Y, Kono T, Miyazaki T et al. The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol 1993;11:245-68.
4. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996;87:13-20.
5. May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol Today 1998;19:80-88.
6. Miescher S, Stoeck M, Qiao L et al. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression. Int J Cancer 1988;42:659-666.
7. Yoshino I, Yano T, Murata M et al. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res 1992;52:775-781.
8. Alexander JP, Kudoh S, Melsop KA et al. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res 1993;53:1380-1387.
9. Tartour E, Latour S, Mathiot C et al. Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 1995;63:205-212.
10. Finke JH, Tubbs R, Connelly B et al. Tumor-infiltrating lymphocytes in patients with renal-cell carcinoma. Ann NY Acad Sci 1988;532:387-394.
11. Wang Q, Redovan C, Tubbs R et al. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 1995;61:780-785.
12. Nakagomi H, Pisa P, Pisa EK et al. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 1995;63:366-371.
13. Pisa P, Halapi E, Pisa EK et al. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992;89:7708-7712.
14. Kolenko V, Wang Q, Riedy MC et al. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. J Immunol 1997;159:3057-3067.
15. Kolenko V, Bloom T, Rayman P et al. Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol 1999;163:590-598.
16. Ling W, Rayman P, Uzzo R et al. Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalpha. Blood 1998;92:1334-1341.
17. Ladisch S, Gillard B. A solvent partition method for microscale ganglioside purification. Anal Biochem 1985;146:220-231.
18. Uzzo RG, Clark PE, Rayman P et al. Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma. J Natl Cancer Inst 1999;91:718-721.
19. Uzzo R, Rayman P, Kolenko V et al. Renal cell carcinoma-derived gangliosides suppress NF-kappaB activation in T cells. J Clin Invest 1999;104:769-776.
20. Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 1990;265:18713-18716.
21. Ritter G, Livingston PO. Ganglioside antigens expressed by human cancer cells. Semin Cancer Biol 1991;2:401-409.
22. Hoon DS, Okun E, Neuwirth H et al. Aberrant expression of gangliosides in human renal cell carcinomas. J Urol 1993;150:2013-2018.
23. Kong Y, Li R, Ladisch S. Natural forms of shed tumor gangliosides. Biochim Biophys Acta 1998;1394:43-56.
24. Ladisch S, Ulsh L, Gillard B et al. Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro. J Clin Invest 1984;74:2074-2081.
25. Li R, Villacreses N, Ladisch S. Human tumor gangliosides inhibit murine immune responses in vivo. Cancer Res 1995;55:211-214.
26. Irani DN, Lin KI, Griffin DE. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J Immunol 1996;157:4333-4340.
27. Minakuchi R, Wacholtz MC, Davis LS et al. Delineation of the mechanism of inhibition of human T cell activation by PGE2. J Immunol 1990;145:2616-2625.
28. de Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-4765.
29. Romano MF, Lamberti A, Petrella A et al. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes. J Immunol 1996;156:2119-2123.
30. Chen D, Rothenberg EV. Intetleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 1994;179:931-942.
31. Kono K, Salazar-Onfray F, Petersson M et al. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-ttansducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol 1996;26:1308-1313.
32. Otsuji M, Kimura Y, Aoe T et al. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Nad Acad Sci USA 1996;93:13119-13124.
33. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996;274:782-784.
34. Wang CY, Mayo MW, Korneluk RG et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
35. Dudley E, Hornung F, Zheng L et al. NF-kappaB regulates Fas/APO-1/CD95-and TCR-mediated apoptosis of T lymphocytes. Eur J Immunol 1999;29:878-886.